DPP-4 is an important marker of obesity and its complications, particularly diabetes mellitus, which is actively used as a target for therapy and the development of drugs that reduce blood glucose levels. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.